Following the announcement of the updated interim results for a clinical trial, shares of Janux Therapeutics, Inc. (NASDAQ: JANX) are jumping sharply on the charts
Janux Therapeutics, Inc. (NASDAQ: JANX) has experienced a notable surge in its stock value, climbing by 193.08% to reach $44.26 on the US charts. This
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.